New COVID-19 nasal spray outperforms current antibody treatments in mice?
The Pharma Data
APRIL 15, 2022
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat COVID-19. “Our minibinders sit on top of the spike protein like a tripod and block all three.
Let's personalize your content